Sandbox/00007: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 105: Line 105:


{{Family tree/start}}
{{Family tree/start}}
{{Family tree|boxstyle=width: 400px; text-align: left; font-size: 90%;| | | | | | | | | A01 | | |A01=<div style="padding: 15px;"><BIG>'''Does the patient have cardinal findings that increase the pretest probability of cardiogenic shock?'''</BIG>
{{Family tree|boxstyle=width: 400px; text-align: left; font-size: 90%; padding: 0px;| | | | | A01 | | | |A01=<div style="padding: 15px;"><BIG>'''Does the patient have cardinal findings that increase the pretest probability of cardiogenic shock?'''</BIG>
❑&nbsp;&nbsp;'''Arterial hypotension'''
: ❑&nbsp;&nbsp;[[SBP|<span style="color: #000000;">SBP</span>]] &lt;90 mm Hg ''or''
: ❑&nbsp;&nbsp;[[MAP|<span style="color: #000000;">MAP</span>]] ↓ &gt;30 mm Hg below baseline


❑&nbsp;&nbsp;'''Evidence of tissue hypoperfusion'''
❑&nbsp;&nbsp;Evidence of hypoperfusion
: ❑&nbsp;&nbsp;[[Altered mental status|<span style="color: #000000;">Altered mental status</span>]]
: ❑&nbsp;&nbsp;[[Altered mental status|<span style="color: #000000;">Altered mental status</span>]]
: ❑&nbsp;&nbsp;[[Cool extremities|<span style="color: #000000;">Cool extremities</span>]]
: ❑&nbsp;&nbsp;[[Cool extremities|<span style="color: #000000;">Cool extremities</span>]]
: ❑&nbsp;&nbsp;[[Cyanosis|<span style="color: #000000;">Cyanosis</span>]]
: ❑&nbsp;&nbsp;[[Cyanosis|<span style="color: #000000;">Cyanosis</span>]]
: ❑&nbsp;&nbsp;[[Oliguria|<span style="color: #000000;">Oliguria</span>]]
: ❑&nbsp;&nbsp;[[Oliguria|<span style="color: #000000;">Oliguria</span>]]
: ❑&nbsp;&nbsp;Sustained hypotension
:: ❑&nbsp;&nbsp;[[SBP|<span style="color: #000000;">SBP</span>]] &lt;90 mm Hg for ≥30 min ''or''
:: ❑&nbsp;&nbsp;[[MAP|<span style="color: #000000;">MAP</span>]] ↓ &gt;30 mm Hg below baseline for ≥30 min


❑&nbsp;&nbsp;'''Presence of myocardial dysfunction after exclusion or correction of non-myocardial factors contributing to tissue hypoperfusion'''</div>}}
❑&nbsp;&nbsp;Presence of myocardial dysfunction after exclusion or correction of non-myocardial factors contributing to tissue hypoperfusion</div>}}
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 400px;| | | | | | | | | |!| | }}
{{Family tree|boxstyle=text-align: left; font-size: 90%;| |,|-|-|-|^|-|-|-|.| |}}
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 400px;| | |,|-|-|-|-|-|-|^|-|-|-|-|-|.|}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A02 | | | | | | A03 |A02=<div style="text-align: center; background: #FA8072; color: #F8F8FF; padding: 15px; font-weight: bold;"><BIG>YES</BIG></div>|A03=<div style="text-align: center; background: #FA8072; color: #F8F8FF; font-weight: bold; padding: 15px;"><BIG>NO</BIG></div>}}
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 400px;| | A02 | | | | | | | | | | | | A03 |A02=<div style="text-align: center; background: #FA8072; color: #F8F8FF; padding: 5px; font-weight: bold;">YES</div>|A03=<div style="text-align: center; font-weight: bold;">NO</div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | |!| |}}
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 400px;| | |!| | | | | | | | | | | | |!|}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A04 | | | | | | A05 |A04=<div style="text-align: center; background: #FA8072; color: #F8F8FF; padding: 15px; font-weight: bold;"><BIG>Cardiogenic <br> shock <br> suspected</BIG></div>
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 400px;| | A04 | | | | | | | | | | | | A05 |A04=<div style="text-align: left; background: #FA8072; color: #F8F8FF; padding: 15px;">
|A05=<div style="text-align: center; background: #FA8072; color: #FFFFFF; padding: 15px; font-weight: bold;"><BIG>'''Proceed to <br> [[shock resident survival guide|<span style="color: #FFFFFF;">shock resident survival guide</span>]] <br> to identify and correct the cause'''</BIG></div>}}
'''Ventilate—Infuse—Pump (VIP)'''
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A06 | | | | | | | | |A06=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate management'''</BIG>


❑&nbsp;&nbsp;[[Oxygen therapy|<span style="color: #FFFFFF;">Oxygen</span>]] ± intubation with [[mechanical ventilation|<span style="color: #FFFFFF;">mechanical ventilation</span>]]
❑&nbsp;&nbsp;[[Intubation|<span style="color: #FFFFFF;">Intubation</span>]] with [[mechanical ventilation|<span style="color: #FFFFFF;">mechanical ventilation</span>]]


❑&nbsp;&nbsp;[[Normal saline|<span style="color: #FFFFFF;">Normal saline 300–500 mL over 20–30 min</span>]]
❑&nbsp;&nbsp;± IV bolus [[Normal saline|<span style="color: #FFFFFF;">normal saline</span>]] 100–200 mL


❑&nbsp;&nbsp;± [[Norepinephine|<span style="color: #FFFFFF;">Norepinephrine 0.1–2.0 μg/kg/min</span>]]</div>
❑&nbsp;&nbsp;± [[Norepinephine|<span style="color: #FFFFFF;">Norepinephrine</span>]] 0.1–2.0 μg/kg/min
|A05=<div style="text-align: center; padding: 15px;">Consider other causes (eg, [[chronic hypotension|<span style="color: #000000;">chronic hypotension</span>]], [[syncope|<span style="color: #000000;">syncope</span>]])</div>}}
 
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 250px;| | |!| }}
❑&nbsp;&nbsp;± Control pain and/or anxiety
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 450px;| | A06 |A06=<div style="text-align: left; background: #FA8072; color: #F8F8FF; padding: 15px;">
: ❑&nbsp;&nbsp;[[Morphine sulphate|<span style="color: #FFFFFF;">Morphine sulphate</span>]]
'''Workup'''
 
: ❑&nbsp;&nbsp;[[Fentanyl|<span style="color: #FFFFFF;">Fentanyl</span>]]
 
❑&nbsp;&nbsp;[[Cardiology|<span style="color: #FFFFFF;">Cardiology consultation</span>]]</div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A07 | | | | | | | | |A07=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Workup'''</BIG>


❑&nbsp;&nbsp;[[ECG|<span style="color: #FFFFFF;">ECG monitor</span>]]
❑&nbsp;&nbsp;[[ECG|<span style="color: #FFFFFF;">ECG monitor</span>]]
Line 141: Line 147:


❑&nbsp;&nbsp;[[Central venous catheter|<span style="color: #FFFFFF;">Central venous catheter</span>]]
❑&nbsp;&nbsp;[[Central venous catheter|<span style="color: #FFFFFF;">Central venous catheter</span>]]
❑&nbsp;&nbsp;[[Pulmonary artery catheter|<span style="color: #FFFFFF;">Pulmonary artery catheter</span>]]


❑&nbsp;&nbsp;[[CBC|<span style="color: #FFFFFF;">CBC</span>]]/[[Differential blood count (patient information)|<span style="color: #FFFFFF;">DC</span>]]/[[Basic metabolic panel|<span style="color: #FFFFFF;">SMA-7</span>]]/[[LFT|<span style="color: #FFFFFF;">LFT</span>]]/[[PT|<span style="color: #FFFFFF;">PT</span>]]/[[PTT|<span style="color: #FFFFFF;">PTT</span>]]/[[INR|<span style="color: #FFFFFF;">INR</span>]]
❑&nbsp;&nbsp;[[CBC|<span style="color: #FFFFFF;">CBC</span>]]/[[Differential blood count (patient information)|<span style="color: #FFFFFF;">DC</span>]]/[[Basic metabolic panel|<span style="color: #FFFFFF;">SMA-7</span>]]/[[LFT|<span style="color: #FFFFFF;">LFT</span>]]/[[PT|<span style="color: #FFFFFF;">PT</span>]]/[[PTT|<span style="color: #FFFFFF;">PTT</span>]]/[[INR|<span style="color: #FFFFFF;">INR</span>]]
Line 155: Line 163:


❑&nbsp;&nbsp;[[ICU|<span style="color: #FFFFFF;">ICU admission</span>]]
❑&nbsp;&nbsp;[[ICU|<span style="color: #FFFFFF;">ICU admission</span>]]
❑&nbsp;&nbsp;± [[Transfusion|<span style="color: #FFFFFF;">Transfusion</span>]] '''''([[Transfusion therapy resident survival guide|<span style="color: #FFFFFF;">Indications</span>]])'''''
❑&nbsp;&nbsp;± [[Culture|<span style="color: #FFFFFF;">Cultures of blood, urine, etc.</span>]]
❑&nbsp;&nbsp;± [[Pulmonary artery catheter|<span style="color: #FFFFFF;">Pulmonary artery catheter</span>]] '''''([[Right heart catheterization#Indications|<span style="color: #FFFFFF;">Indications</span>]])'''''
</div>}}
</div>}}
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 250px;| | |!| }}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 250px;| | A07 |A07=<div style="text-align: left; background: #FA8072; color: #F8F8FF; padding: 15px;">
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A08 | | | | | | | | |A08=<div style="background: #FA8072; color: #F8F8FF; padding: 15px;"><BIG>'''Immediate goals'''</BIG>
'''Immediate goals'''


❑&nbsp;&nbsp;[[SaO2|<span style="color: #FFFFFF;">SaO2 &gt;90%–92%</span>]]
❑&nbsp;&nbsp;[[SaO2|<span style="color: #FFFFFF;">SaO2 &gt;90%–92%</span>]]
Line 185: Line 186:


❑&nbsp;&nbsp;[[urine output|<span style="color: #FFFFFF;">Urine output >0.5 mL/kg/h</span>]]
❑&nbsp;&nbsp;[[urine output|<span style="color: #FFFFFF;">Urine output >0.5 mL/kg/h</span>]]
</div>}}
 
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 250px;| | |!| }}
❑&nbsp;&nbsp;± Correct [[arrhythmia|<span style="color: #FFFFFF;">arrhythmia</span>]]
{{Family tree|boxstyle=font-size: 90%; text-align: left; padding: 0; background: #FA8072;| | C00 | | |C00=<div style="background: #FA8072; color: #F8F8FF; padding: 15px; text-align: center">'''Identify the cause'''</div>}}
 
{{Family tree|boxstyle=font-size: 90%; text-align: left;| | |!| | | |}}
❑&nbsp;&nbsp;± Correct [[electrolyte disturbance|<span style="color: #FFFFFF;">electrolyte disturbance</span>]]</div>}}
{{Family tree|boxstyle=padding: 0; font-size: 90%; width: 500px;| | A08 |A08=<div style="text-align: center; background: #FA8072; color: #F8F8FF; padding: 5px;">'''NO''', then proceed to <br>[[{{PAGENAME}}#Complete Diagnostic Approach|<span style="color: #FFFFFF;">complete diagnostic approach</span>]] below</div>}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| |!| | | | | | | | | |}}
{{Family tree|boxstyle=text-align: left; font-size: 90%; padding: 0px;| A09 | | | | | | | | |A09=<div style="text-align: center; background: #FA8072; color: #FFFFFF; font-weight: bold; padding: 15px;"><BIG>Proceed to <br> [[{{PAGENAME}}#Complete Diagnostic Approach|<span style="color: #FFFFFF;">complete diagnostic approach</span>]] <br> below</BIG></div>}}
{{Family tree/end}}
{{Family tree/end}}



Revision as of 17:03, 18 April 2014

Cardiogenic shock
Resident Survival Guide
Overview
Causes
FIRE
Diagnosis
Treatment
Do's
Don'ts

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, MBChB. [2]

Overview

The clinical definition of cardiogenic shock includes decreased cardiac output with evidence of tissue hypoxia in the presence of adequate intravascular volume.[1]

Diagnositic Criteria

Criteria for bedside diagnosis[1][2][3]

Criteria based on hemodynamic parameters[1][3][4][5][6]

Causes

Life Threatening Causes

Cardiogenic shock is a life-threatening condition and must be treated as such irrespective of the underlying cause.

Common Causes

  • Arrhythmic
  • Mechanical
  • Myopathic
  • Pharmacologic

Click here for the complete list of causes.

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.

Boxes in the salmon color signify that an urgent management is needed.

Abbreviations: CBC, complete blood count; CI, cardiac index; CK-MB, creatine kinase MB isoform; CVP, central venous pressure; DC, differential count; ICU, intensive care unit; INR, international normalized ratio; LFT, liver function test; MAP, mean arterial pressure; MVO2, mixed venous oxygen saturation; PCWP, pulmonary capillary wedge pressure; PT, prothrombin time; PTT, partial prothrombin time; SaO2, arterial oxygen saturation; SBP, systolic blood pressure; SCVO2, central venous oxygen saturation; SMA-7, sequential multiple analysis-7.

 
 
 
 
Does the patient have cardinal findings that increase the pretest probability of cardiogenic shock?

❑  Evidence of hypoperfusion

❑  Altered mental status
❑  Cool extremities
❑  Cyanosis
❑  Oliguria
❑  Sustained hypotension
❑  SBP <90 mm Hg for ≥30 min or
❑  MAP ↓ >30 mm Hg below baseline for ≥30 min
❑  Presence of myocardial dysfunction after exclusion or correction of non-myocardial factors contributing to tissue hypoperfusion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
 
 
NO
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardiogenic
shock
suspected
 
 
 
 
 
Proceed to
shock resident survival guide
to identify and correct the cause
 
 
 
 
 
 
 
 
 
 
 
 
Immediate management

❑  Intubation with mechanical ventilation

❑  ± IV bolus normal saline 100–200 mL

❑  ± Norepinephrine 0.1–2.0 μg/kg/min

❑  ± Control pain and/or anxiety

❑  Morphine sulphate
❑  Fentanyl
❑  Cardiology consultation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Immediate goals

❑  SaO2 >90%–92%

❑  CVP 8–12 mm Hg

❑  MAP >60 mm Hg

❑  PCWP 14–18 mm Hg

❑  CI >2.2 L/min/m2

❑  MVO2 >60%

❑  SCVO2 >70%

❑  Hemoglobin >7–9 g/dL

❑  Lactate <2.2 mM/L

❑  Urine output >0.5 mL/kg/h

❑  ± Correct arrhythmia

❑  ± Correct electrolyte disturbance
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Complete Diagnostic Approach

History
  • Review all medications
  • Findings suggestive of hypovolemic shock
  • Findings suggestive of cardiogenic shock
  • Findings suggestive of distributive shock
Physical Examination
  • Vital signs
  • Temperature
  • Pulse
  • Respiration
  • Blood pressure
  • Mental status
  • Cutaneous
  • Neck
  • Cardiovascular
  • Pulmonary
  • Abdominal
  • Rectal
  • Extremities
  • Genitals
  • Neurologic
Laboratory Findings
  • Complete blood count
  • Electrolytes
  • Coagulation panel (PT, PTT, INR, etc.)
  • Cardiac markers
  • Liver function
  • Renal function
  • Lactate
  • Hyperlactatemia generally reflects the development of anaerobic metabolism in hypoperfused tissue and/or imparied hepatic clearance.
  • Lactate level could decrease within hours with effective therapy.[7]
  • Arterial blood gas
  • Cultures
  • Nasogastric aspirate
  • Pregnancy test
ECG Findings
Radiographic Findings
  • CT scan may aid in directing management in the following conditions:
Hemodynamic Profiles and Echocardiography Findings
Type of Shock Etiology CO SVR PCWP CVP SVO2 Echocardiographic Findings
Cardiogenic Acute Ventricular Septal Defect ↓↓ N — ↑ ↑↑ ↑ — ↑↑ Large ventricles with poor contractility
Acute Mitral Regurgitation ↓↓ ↑↑ ↑ — ↑↑
Myocardial Dysfunction ↓↓ ↑↑ ↑↑
RV Infarction ↓↓ N — ↓ ↑↑ Dilated RV, small LV, abnormal wall motions
Obstructive Pulmonary Embolism ↓↓ N — ↓ ↑↑ Dilated RV, small LV
Cardiac Tamponade ↓ — ↓↓ ↑↑ ↑↑ Pericardial effusion, small ventricles, dilated inferior vena cava
Distributive Septic Shock N — ↑↑ ↓ — ↓↓ N — ↓ N — ↓ ↑ — ↑↑ Normal cardiac chambers with preserved contractility
Anaphylactic Shock N — ↑↑ ↓ — ↓↓ N — ↓ N — ↓ ↑ — ↑↑
Hypovolemic Volume Depletion ↓↓ ↓↓ ↓↓ Small cardiac chambers with normal or high contractility

Treatment

Do's

  • Initial Management
  • Resuscitation should be initiated while investigation is ongoing. Correct the cause of shock immediately once it is identified.
  • The VIP (Ventilate-Infuse-Pump) approach is useful for ensuring an orderly sequence of therapeutic-diagnostic maneuvers.[8]
  • Ventilate
  • Infuse
  • Pump

Don'ts

References

  1. 1.0 1.1 1.2 Califf, RM.; Bengtson, JR. (1994). "Cardiogenic shock". N Engl J Med. 330 (24): 1724–30. doi:10.1056/NEJM199406163302406. PMID 8190135. Unknown parameter |month= ignored (help)
  2. Hollenberg, SM.; Kavinsky, CJ.; Parrillo, JE. (1999). "Cardiogenic shock". Ann Intern Med. 131 (1): 47–59. PMID 10391815. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Goldberg, RJ.; Gore, JM.; Alpert, JS.; Osganian, V.; de Groot, J.; Bade, J.; Chen, Z.; Frid, D.; Dalen, JE. (1991). "Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988". N Engl J Med. 325 (16): 1117–22. doi:10.1056/NEJM199110173251601. PMID 1891019. Unknown parameter |month= ignored (help)
  4. Forrester, JS.; Diamond, G.; Chatterjee, K.; Swan, HJ. (1976). "Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts)". N Engl J Med. 295 (24): 1356–62. doi:10.1056/NEJM197612092952406. PMID 790191. Unknown parameter |month= ignored (help)
  5. Forrester, JS.; Diamond, G.; Chatterjee, K.; Swan, HJ. (1976). "Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts)". N Engl J Med. 295 (25): 1404–13. doi:10.1056/NEJM197612162952505. PMID 790194. Unknown parameter |month= ignored (help)
  6. Reynolds, HR.; Hochman, JS. (2008). "Cardiogenic shock: current concepts and improving outcomes". Circulation. 117 (5): 686–97. doi:10.1161/CIRCULATIONAHA.106.613596. PMID 18250279. Unknown parameter |month= ignored (help)
  7. Vincent, JL.; De Backer, D. (2013). "Circulatory shock". N Engl J Med. 369 (18): 1726–34. doi:10.1056/NEJMra1208943. PMID 24171518. Unknown parameter |month= ignored (help)
  8. Weil, MH.; Shubin, H. (1969). "The VIP approach to the bedside management of shock". JAMA. 207 (2): 337–40. PMID 5818156. Unknown parameter |month= ignored (help)
  9. Dellinger, RP.; Levy, MM.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, SM.; Sevransky, JE.; Sprung, CL.; Douglas, IS. (2013). "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012". Crit Care Med. 41 (2): 580–637. doi:10.1097/CCM.0b013e31827e83af. PMID 23353941. Unknown parameter |month= ignored (help)